Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s Punjab State Bans Drug Rep Visits To Docs During Patient Hours

This article was originally published in PharmAsia News

Executive Summary

The government of the Indian state of Punjab has banned physician meetings with pharmaceutical representatives during working hours. Punjab's Medical Education and Research minister said the ban is aimed at such encounters during the visiting hours of general patients. The intent is to avoid such meetings, which often cause patients to have to wait longer to see their physician, sometimes for hours. The rule is to apply to all doctors, in public or private practice, who work in medical institutes and hospitals. The rule allows the meetings after 2 p.m. if the doctor has seen all waiting patients. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts